Year |
Citation |
Score |
2021 |
Marijon H, Gery S, Chang H, Landesman Y, Shacham S, Lee DH, de Gramont A, Koeffler HP. Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation status. Oncotarget. 12: 1749-1762. PMID 34504648 DOI: 10.18632/oncotarget.28047 |
0.432 |
|
2018 |
Marijon H, Lee DH, Ding L, Sun H, Gery S, de Gramont A, Koeffler HP. Co-targeting poly(ADP-ribose) polymerase (PARP) and histone deacetylase (HDAC) in triple-negative breast cancer: Higher synergism in BRCA mutated cells. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 99: 543-551. PMID 29902865 DOI: 10.1016/J.Biopha.2018.01.045 |
0.439 |
|
2017 |
Xie J, Lin D, Lee DH, Akunowicz J, Hansen M, Miller C, Sanada M, Kato M, Akagi T, Kawamata N, Ogawa S, Koeffler HP. Copy number analysis identifies tumor suppressive lncRNAs in human osteosarcoma. International Journal of Oncology. PMID 28197627 DOI: 10.3892/Ijo.2017.3864 |
0.362 |
|
2015 |
Kanojia D, Nagata Y, Garg M, Lee DH, Sato A, Yoshida K, Sato Y, Sanada M, M T A, Bartenhagen C, Klein HU, Doan NB, Said JW, Mohith S, Gunasekar S, et al. Genomic landscape of liposarcoma. Oncotarget. PMID 26643872 DOI: 10.18632/Oncotarget.6464 |
0.468 |
|
2015 |
Lee DH, Forscher C, Di Vizio D, Koeffler HP. Induction of p53-independent apoptosis by ectopic expression of HOXA5 in human liposarcomas. Scientific Reports. 5: 12580. PMID 26219418 DOI: 10.1038/Srep12580 |
0.43 |
|
2015 |
Lee DH, Qi J, Bradner JE, Said JW, Doan NB, Forscher C, Yang H, Koeffler HP. Synergistic effect of JQ1 and rapamycin for treatment of human osteosarcoma. International Journal of Cancer. Journal International Du Cancer. 136: 2055-64. PMID 25307878 DOI: 10.1002/Ijc.29269 |
0.478 |
|
2015 |
Kanojia D, Garg M, Nagata Y, Lee DH, Klein H, Bartenhagen C, T AM, Doan NB, Said JW, Yang H, Forscher C, Dugas M, Ogawa S, Koeffler HP. Abstract A2-20: Integrative study of genomic alterations in liposarcoma Cancer Research. 75. DOI: 10.1158/1538-7445.Transcagen-A2-20 |
0.458 |
|
2014 |
Chien W, Lee DH, Zheng Y, Wuensche P, Alvarez R, Wen DL, Aribi AM, Thean SM, Doan NB, Said JW, Koeffler HP. Growth inhibition of pancreatic cancer cells by histone deacetylase inhibitor belinostat through suppression of multiple pathways including HIF, NFkB, and mTOR signaling in vitro and in vivo. Molecular Carcinogenesis. 53: 722-35. PMID 23475695 DOI: 10.1002/Mc.22024 |
0.487 |
|
2013 |
Lee DH, Amanat S, Goff C, Weiss LM, Said JW, Doan NB, Sato-Otsubo A, Ogawa S, Forscher C, Koeffler HP. Overexpression of miR-26a-2 in human liposarcoma is correlated with poor patient survival. Oncogenesis. 2: e47. PMID 23689287 DOI: 10.1038/oncsis.2013.10 |
0.354 |
|
2013 |
Aribi A, Gery S, Lee DH, Thoennissen NH, Thoennissen GB, Alvarez R, Ho Q, Lee K, Doan NB, Chan KT, Toh M, Said JW, Koeffler HP. The triterpenoid cucurbitacin B augments the antiproliferative activity of chemotherapy in human breast cancer. International Journal of Cancer. Journal International Du Cancer. 132: 2730-7. PMID 23165325 DOI: 10.1002/Ijc.27950 |
0.464 |
|
2011 |
Lee DH, Thoennissen NH, Goff C, Iwanski GB, Forscher C, Doan NB, Said JW, Koeffler HP. Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma. Cancer Letters. 306: 161-70. PMID 21440986 DOI: 10.1016/J.Canlet.2011.03.001 |
0.451 |
|
2010 |
Iwanski GB, Lee DH, En-Gal S, Doan NB, Castor B, Vogt M, Toh M, Bokemeyer C, Said JW, Thoennissen NH, Koeffler HP. Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer. British Journal of Pharmacology. 160: 998-1007. PMID 20590594 DOI: 10.1111/J.1476-5381.2010.00741.X |
0.471 |
|
2010 |
Lee DH, Iwanski GB, Thoennissen NH. Cucurbitacin: Ancient Compound Shedding New Light on Cancer Treatment The Scientific World Journal. 10: 413-418. PMID 20209387 DOI: 10.1100/Tsw.2010.44 |
0.342 |
|
2010 |
Thoennissen NH, Krug UO, Lee DH, Kawamata N, Iwanski GB, Lasho T, Weiss T, Nowak D, Koren-Michowitz M, Kato M, Sanada M, Shih LY, Nagler A, Raynaud SD, Müller-Tidow C, et al. Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms. Blood. 115: 2882-90. PMID 20068225 DOI: 10.1182/Blood-2009-07-235119 |
0.322 |
|
2010 |
Lee DH, Thoennissen NH, Goff CB, Iwanski GB, Doan NB, Toh M, Chan T, Said JW, Koeffler HP. Abstract 5396: Synergistic effect of cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma Cancer Research. 70: 5396-5396. DOI: 10.1158/1538-7445.Am10-5396 |
0.474 |
|
Show low-probability matches. |